CD47 ANTIBODY, AO-176 DEMONSTRATES POTENT ANTI-TUMOR ACTIVITY IN PRE-CLINICAL SOLID TUMOR XENOGRAFTS AS A SINGLE AGENT AND IN COMBINATION WITH MULTIPLE CLASSES OF THERAPEUTICSJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-11-100OA
Novel SIRPα Antibodies That Induce Single-Agent Phagocytosis of Tumor Cells while Preserving T CellsJOURNAL OF IMMUNOLOGYIF3.42021-02-1543OA
AO-176, A HIGHLY DIFFERENTIATED CLINICAL STAGE ANTI-CD47 ANTIBODY, PREFERENTIALLY BINDS TUMOR VERSUS NORMAL CELL CD47 WHEN COMPLEXED TO β1 INTEGRINJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62020-12-100OA
Development of AO-176, a Next-Generation Humanized Anti-CD47 Antibody with Novel Anticancer Properties and Negligible Red Blood Cell BindingMOLECULAR CANCER THERAPEUTICSIF5.52020-03-0266OAAI
AO-176, a highly differentiated humanized anti-CD47 antibody, exhibits single -agent and combination antitumor efficacy with chemotherapy and targeted antibodiesMOLECULAR CANCER THERAPEUTICSIF5.52019-12-011PRE
A humanized anti-CD47 monoclonal antibody that directly kills human tumor cells and has additional unique functional characteristicsCANCER RESEARCHIF16.62018-07-012PRE
Anti-CD47 monoclonal antibody therapy reduces ischemia-reperfusion injury of renal allografts in a porcine model of donation after cardiac deathAMERICAN JOURNAL OF TRANSPLANTATIONIF8.22018-04-0126OAAI
Attenuation of Ischemia-Reperfusion Injury and Improvement of Survival in Recipients of Steatotic Rat Livers Using CD47 Monoclonal AntibodyTRANSPLANTATIONIF52016-07-0121PREAI
Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinomaCANCER LETTERSIF10.12015-05-01149OAAI
CD47 Blockade Reduces Ischemia/Reperfusion Injury and Improves Survival in a Rat Liver Transplantation ModelLIVER TRANSPLANTATIONIF3.92015-01-2934OAAI
CD47 Blockade Reduces Ischemia-Reperfusion Injury and Improves Outcomes in a Rat Kidney Transplant Model在大鼠肾移植模型中,CD47阻断可减少缺血再灌注损伤并改善预后TRANSPLANTATIONIF52014-08-2735OAAI
Piperazinyl Glutamate Pyridines as Potent Orally Bioavailable P2Y12 Antagonists for Inhibition of Platelet AggregationJOURNAL OF MEDICINAL CHEMISTRYIF6.82010-02-0842PREAI
aph-1 and pen-2 are required for notch pathway signaling, γ-secretase cleavage of βAPP, and presenilin protein accumulationDEVELOPMENTAL CELLIF8.72002-07-01834OA
Caspase activation in MCF7 cells responding to etoposide treatmentMOLECULAR PHARMACOLOGYIF31998-03-0172PREAI